Page 49 - MEMORIA SEHH 2018
P. 49

  PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2018
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• EHA-SWG Scientific Meeting on New Molecular Insights and Innovative Management Approaches for Acute Lym- phoblastic Leukemia. Barcelona, Spain. April 12-14, 2018.
• 46 Reunión Anual PETHEMA. San Sebastián, 24-26 de mayo de 2018.
Publicaciones en revistas científicas
• Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, González-Campos J, Moreno MJ, Barba P, Cervera M, Barrios M, Novo A, Bernal T, Hernández-Rivas JM, Abella E, Amigo ML, Tormo M, Martino R, Lavilla E, Bergua J, Serrano A, García-Belmonte D, Guàrdia R, Grau J, Feliu E. Frequency and prognostic significance of addi- tional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lympho- blastic leukemia. Leuk Lymphoma. 2018 Jan; 59(1):146-54. doi: 10.1080/10428194.2017.1326596.
• Barba P, Martino R, Zhou Q, Cho C, Castro-Malaspina H, Devlin S, Esquirol A, Giralt S, Jakubowski AA, Caballero D, Maloy M, Papadopoulos EB, Piñana JL, Fox ML, Márquez-Malaver FJ, Valcárcel D, Solano C, López-Corral L, Sierra J, Perales MA. CD34(+) Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelo- dysplastic Syndrome. Biol Blood Marrow Transplant. 2018 Jan 2. pii: S1083-8791(17)31839-6. doi: 10.1016/j.bbmt. 2017.12.804.
• Díez-Campelo M, Lorenzo JI, Itzykson R, Rojas SM, Berthon C, Luño E, Beyne-Rauzy O, Pérez-Oteyza J, Vey N, Bargay J, Park S, Cedena T, Bordessoule D, Muñoz JA, Gyan E, Such E, Visanica S, López-Cadenas F, de Botton S, Hernán- dez-Rivas JM, Ame S, Stamatoullas A, Delaunay J, Salanoubat C, Isnard F, Guieze R, Pérez Guallar J, Badiella L, Sanz G, Cañizo C, Fenaux P. Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries. Br J Haematol. 2018 Apr 2. doi: 10.1111/bjh.15190.
• Martín R, Acha P, Ganster C, Palomo L, Dierks S, Fuster-Tormo F, Mallo M, Ademà V, Gómez-Marzo P, De Haro N, Solanes N, Zamora L, Xicoy B, Shirneshan K, Flach J, Braulke F, Schanz J, Kominowski A, Stromburg M, Brockmann A, Trümper L, Solé F, Haase D. Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes. Am J Hematol. 2018 Mar 25. doi: 10.1002/ajh.25089.
• Montoro J, Gallur L, Merchán B, Molero A, Roldán E, Martínez-Valle F, Villacampa G, Navarrete M, Ortega M, Castellví J, Saumell S, Bobillo S, Bosch F, Valcárcel D. Autoimmune disorders are common in myelodysplastic syndrome pa- tients and confer an adverse impact on outcomes. Ann Hematol. 2018 Mar 23. doi: 10.1007/s00277-018-3302-0.
• Palomo L, Malinverni R, Cabezón M, Xicoy B, Arnan M, Coll R, Pomares H, García O, Fuster-Tormo F, Grau J, Feliu E, Solé F, Buschbeck M, Zamora L. DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features. Epigenetics. 2018;13(1):8-18.
• Montes P, Kerick M, Bernal M, Hernández Mohedo F, Jiménez P, Garrido P, Márquez A, Jurado, Martín J, Ruiz-Ca- bello F. Diferencias en perfil Clínico-Biológico y Mutacional en Síndromes Mielodisplásicos Hipoplásicos, SMD asociados a del(5q) y SMD Hiper/Normocelulares. Genomic loss of HLA alleles changes the clinical outcome in low-risk myelodysplastic syndrome patients. Submitted to Oncotarget 2018.
• Hurtado AM, Luengo-Gil G, Chen-Liang TH, Amaral F, Batta K, Palomo L, Lumbreras E, Przychodzen B, Capar- rós E, Amigo ML, Díez-Campelo M, Zamora L, Salido Fiérrez EJ, Maciejewski JP, Ortuño FJ, Vicente V, Del Cañizo M, Solé F, Ferrer-Marín F, Wiseman DH, Jerez A. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia. Br J Haematol. 2018 May 24. doi: 10.1111/ bjh.15408.
49
 


















































































   47   48   49   50   51